|
Name |
(1S,4R,7S,8aR)-4-[(2E,4E)-6,8-dimethyldeca-2,4-dienoyl]oxy-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalene-1-carboxylic acid
|
Molecular Formula | C27H36O6 | |
IUPAC Name* |
(1S,4R,7S,8aR)-4-[(2E,4E)-6,8-dimethyldeca-2,4-dienoyl]oxy-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalene-1-carboxylic acid
|
|
SMILES |
CCC(C)CC(C)/C=C/C=C/C(=O)O[C@@H]1CC[C@@H]([C@@]2(C1=CC(=O)[C@@H](C2)C(=C)C=O)C)C(=O)O
|
|
InChI |
InChI=1S/C27H36O6/c1-6-17(2)13-18(3)9-7-8-10-25(30)33-24-12-11-21(26(31)32)27(5)15-20(19(4)16-28)23(29)14-22(24)27/h7-10,14,16-18,20-21,24H,4,6,11-13,15H2,1-3,5H3,(H,31,32)/b9-7+,10-8+/t17?,18?,20-,21+,24+,27+/m0/s1
|
|
InChIKey |
KFNRVRQZGWBRJR-XQLFHWRFSA-N
|
|
Synonyms |
07H239-A; CHEMBL515687; (1S,4R,7S,8aR)-4-[(2E,4E)-6,8-dimethyldeca-2,4-dienoyl]oxy-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalene-1-carboxylic acid
|
|
CAS | NA | |
PubChem CID | 11294029 | |
ChEMBL ID | CHEMBL515687 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 456.6 | ALogp: | 4.7 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 97.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 33 | QED Weighted: | 0.209 |
Caco-2 Permeability: | -5.1 | MDCK Permeability: | 0.00002490 |
Pgp-inhibitor: | 0.077 | Pgp-substrate: | 0.056 |
Human Intestinal Absorption (HIA): | 0.28 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.513 | Plasma Protein Binding (PPB): | 91.93% |
Volume Distribution (VD): | 0.23 | Fu: | 2.73% |
CYP1A2-inhibitor: | 0.021 | CYP1A2-substrate: | 0.084 |
CYP2C19-inhibitor: | 0.134 | CYP2C19-substrate: | 0.234 |
CYP2C9-inhibitor: | 0.678 | CYP2C9-substrate: | 0.925 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.115 |
CYP3A4-inhibitor: | 0.215 | CYP3A4-substrate: | 0.216 |
Clearance (CL): | 0.614 | Half-life (T1/2): | 0.898 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.052 |
Drug-inuced Liver Injury (DILI): | 0.058 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.931 |
Skin Sensitization: | 0.973 | Carcinogencity: | 0.627 |
Eye Corrosion: | 0.979 | Eye Irritation: | 0.329 |
Respiratory Toxicity: | 0.939 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004127 | 0.385 | D0FG6M | 0.259 | ||||
ENC003665 | 0.346 | D04SFH | 0.227 | ||||
ENC002770 | 0.344 | D09IEE | 0.225 | ||||
ENC002230 | 0.336 | D08TEJ | 0.225 | ||||
ENC002816 | 0.333 | D02CJX | 0.224 | ||||
ENC002779 | 0.331 | D01ZOG | 0.224 | ||||
ENC004128 | 0.304 | D05RXI | 0.221 | ||||
ENC003895 | 0.293 | D0W5LS | 0.221 | ||||
ENC004660 | 0.293 | D03KYG | 0.221 | ||||
ENC002780 | 0.288 | D0I1LH | 0.220 |